Intrastromal injection of bevacizumab in patients with corneal neovascularization

被引：15

作者：

Cabreira Vieira, Ana Carolina ^{[1
]}

Hoefling-Lima, Ana Luisa ^{[1
]}

Gomes, Jose Alvaro P. ^{[1
]}

de Freitas, Denise ^{[1
]}

Farah, Michel Eid ^{[1
]}

Belfort, Rubens, Jr. ^{[1
]}

机构：

[1] Univ Fed Sao Paulo UNIFESP, Vis Inst, Dept Ophthalmol, Sao Paulo, Brazil

来源：

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA | 2012年 / 75卷 / 04期

关键词：

Corneal stroma/drug effects; Corneal neovascularization/drug therapy; Injections; intraocular; Antibodies; monoclonal/administration; dosage; INTRAVITREAL BEVACIZUMAB; ANGIOGENESIS; LYMPHANGIOGENESIS; SUBCONJUNCTIVAL; AVASTIN;

D O I：

10.1590/S0004-27492012000400012

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Corneal neovascularization (NV) not only reduces visual acuity, but it also causes loss of the cornea's immune privilege, strongly contributing to a worse prognosis in penetrating keratoplasty. Several mediators participate in corneal angiogenesis, and the role of vascular endothelial growth factor (VEGF) has been extensively proven. Anti-VEGF agents have been shown to be effective in slowing the growth of corneal neovessels. Bevacizumab, an anti-VEGF agent, has been successfully used in the treatment of corneal neovascularization. In this paper, we report a series of patients who underwent intracorneal bevacizumab injections to treat corneal vascularization.

引用

页码：277 / 279

页数：3

共 15 条

[1] Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
Avery, RL
Pieramici, DJ
Rabena, MD
Castellarin, AA
Nasir, MA
Giust, MJ
[J]. OPHTHALMOLOGY, 2006, 113 (03) : 363 - 372
[2] Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
Avery, Robert L.
Pearlman, Joel
Pieramici, Dante J.
Rabena, Melvin D.
Castellarin, Alessandro A.
Nasir, Ma'an A.
Giust, Matthew J.
Wendel, Robert
Patel, Arun
[J]. OPHTHALMOLOGY, 2006, 113 (10) : 1695 - 1705
[3] Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation
Bachmann, Bjoern O.
Bock, Felix
Wiegand, Stanley J.
Maruyama, Kazuichi
Dana, M. Reza
Kruse, Friedrich E.
Luetjen-Drecoll, Elke
Cursiefen, Claus
[J]. ARCHIVES OF OPHTHALMOLOGY, 2008, 126 (01) : 71 - 77
[4] Subconjunctival bevacizumab lnjection for corneal neovascularization
Bahar, Irit
Kaiserman, Igor
McAllum, Penny
Rootman, David
Slomovic, Allan
[J]. CORNEA, 2008, 27 (02) : 142 - 147
[5] Corneal neovascularization
Chang, Jin-Hong
Gabison, Eric E.
Kato, Takuji
Azar, Dimitri T.
[J]. CURRENT OPINION IN OPHTHALMOLOGY, 2001, 12 (04) : 242 - 249
[6] Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation
Cursiefen, C
Maruyama, K
Jackson, DG
Streilein, JW
Kruse, FE
[J]. CORNEA, 2006, 25 (04) : 443 - 447
[7] VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
Cursiefen, C
Chen, L
Borges, LP
Jackson, D
Cao, JT
Radziejewski, C
D'Amore, PA
Dana, MR
Wiegand, SJ
Streilein, JW
[J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (07) : 1040 - 1050
[8] Topical Bevacizumab in the Treatment of Corneal Neovascularization
Dastjerdi, Mohammad H.
Al-Arfaj, Khalid M.
Nallasamy, Nambi
Hamrah, Pedram
Jurkunas, Ula V.
Pineda, Roberto, II
Pavan-Langston, Deborah
Dana, Reza
[J]. ARCHIVES OF OPHTHALMOLOGY, 2009, 127 (04) : 381 - 389
[9] Deep Intrastromal Bevacizumab Injection for Management of Corneal Stromal Vascularization After Deep Anterior Lamellar Keratoplasty, A Novel Technique
Hashemian, Mohammad Naser
Zare, Mohammad Ali
Rahimi, Firoozeh
Mohammadpour, Mehrdad
[J]. CORNEA, 2011, 30 (02) : 215 - 218
[10] A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents
Hosseini, Hamid
Nejabat, Mahmood
[J]. MEDICAL HYPOTHESES, 2007, 68 (04) : 799 - 801

← 1 2 →